-
Targeted substances
- Triglyceride
- Bilirubin
- Carbamazepine
- Digoxin
- Methotrexate
- Bile acid
- Paraquat
- Myoglobin
- Cholesterol
- Inflammatory Mediators and Cytokines
- Leptin
- Ammonia
- Protein-bound toxins
- β2-MG
- Organophosphate
- PTH
- Rivaroxaban
- 2,4-dinitrophenol
- Ticagrelor
- Paracetamol
- Metformin
- ANA and ds-DNA titers
- Abrin
- Sodium valproate
- Amlodipine
- Estazolam
- Quetiapine
- Olanzapine
- Ziprasidone
- Vancomycin
- Organophosphorus
- Circulating Bacteria
- Liver Enzymes(e.g. ALT,AST)
- Vancomycin
- Gentamicin
- Poison
- Protein binded substance
- Others
-
Benefits
- Improve QOL
- Decrease Vasopressor Needs
- Stabilize Hemodynamics
- Improve oxygenation
- Bridge to Liver Transplantation
- Reduce the incidence of adverse effect
- Shorten ICU stay
- Reduce bleeding complications
- Reduce Mechanical Ventilation
- Improve Respiratory Function
- Lower the mortality rate
- Improve Liver Function
- Improve sleep efficiency
- Improve HE
- Improve renal function
- Relieve Uremic Pruritis
- Reduce Cardiovascular Related Events
- Improve Survival Rate
- Remove inflammatory markers/ cytokines
- Reduce circulating bacterial load
- Improve disease symptoms
- Improve laboratory parameters
- Others
- Disease
- Endocarditis
- Poisoning/Drug overdose
- Leptospirosis
- Sepsis/ Septic Shock
- Multiple Myeloma
- Severe Acute Pancreatitis(SAP)
- Multiple Organ Dysfunction Syndrome(MODS)
- Rhabdomyolysis
- Dengue
- Leukemia-Sepsis
- Burn
- Trauma
- Open Heart Surgery
- Acute Respiratory Distress Syndrome (ARDS)
- Hepatic Encephalopathy(HE)
- End Stage Renal Disease(ESRD)
- Acute Kidney Injury(AKI)
- Systemic Lupus Erythematosus (SLE)
- Liver Transplantation
- Liver Failure(LF)
- Jaudice
- Subarachnoid Hemorrhage
- Symmetrical Peripheral Gangrene(SPG)
- Wasp Stings
- Acute Renal Failure
- Hepatitis
- Cardiopulmonary Bypass(CPB)
- Severe Liver Injury
- Henoch-Schönlein purpura (HSP)
- COVID-19
- Polymyositis
- Liver Cirrhosis
- Hyperbilirubinemia
- Maintenance Hemodialysis (MHD)
- crush syndrome
- Human Immunodeficiency Virus(HIV)
- Immunological diseases (IMD)
- hyperlipidemia
- Others
-
Care Bundles to Improve Hemoperfusion Performance in Patients with Severe COVID-19: A Retrospective Study
Mueankwan S, Trongtrakul K, Tajarernmuang P, et al. [J]. Journal of Clinical Medicine, 2024, 13(12): 3360.
-
Successful Treatment of Severe Case of Lipid Overload Syndrome with Pancreatitis and Pneumonia: A Case Report
Sun Z G, Xu S C, Yang Q, et al. [J]. International Medical Case Reports Journal, 2024: 471-477.
-
Mortality Rate and Acute Kidney Injury Prevalence Reduction in COVID‑19 Critical Patients Treated with Hemoperfusion
Barriga-Moreno A P, Lozano-Sanchez M, Barón-Alvarez R A, et al. [J]. Indian Journal of Nephrology, 2023: 10.4103.
-
Observation on the Effect of Sequentially Combined Multi-modal Artificial Liver Treatment on HBV-related Acute-on-chronic Liver Failure
Zhou X, Miu Y, Guo X, et al. [J]. Current Molecular Medicine, 2024, 24(9): 1152-1158.
-
Outcome of patients with different stages of acute-on-chronic liver failure treated with artificial liver support system
Ma Y, Xu Y, Du L, et al. [J]. Frontiers in Medicine, 2024, 11: 1381386.
-
The impact of artificial liver support system on intestinal microbiota and serum bile acid profiles in patients with acute-on-chronic liver failure
Zeng Y, Gan D, Zhang K, et al. [J]. 2024.
-
42nd Vicenza Course Abstracts
42nd Vicenza Course on AKI-CRRT-ECOS, 11-13 June 2024, Vicenza, Italy
-
61st ERA Congress Abstracts
ndt Volume 39, Issue Supplement_1 May 2024
-
Blood Purification Therapy in Chronic Renal Failure and its Impact on Renal Index, Serological Index, and Inflammatory Factors
Butt B, Mushtaq A, Hameed F A, et al. [J]. Annals of Medicine and Surgery, 10.1097.
-
Case report and literature review: A thyroid storm patient with severe acute hepatic failure treated by therapeutic plasma exchange and a double plasma molecular absorption system
Tu F, Lin Y, Chen J, et al. [J]. Heliyon, 2024, 10(7).
-
Asian Pacific Association for the Study of the Liver 2024
Asian Pacific Association for the Study of the Liver 2024
-
Evaluation of G3BP1 in the prognosis of acute and acute-on-chronic liver failure after the treatment of artificial liver support system
Li W Y, Wang L W, Dong J, et al. [J]. World Journal of Hepatology, 2024, 16(2): 251.
-
Blood Purification for the Treatment of Chronic Kidney Disease-associated Pruritus
Marcello M, Ramírez-Guerrero G, Reis T, et al. [J]. Integrative Medicine in Nephrology and Andrology, 2024, 11(2): e24-00005.
-
Effectiveness of HA330 hemoperfusion as an adjunctive therapy for severe COVID-19 patients: a single center experience
Phongphithakchai A, Saelu P, Wongpraphairot S, et al. [J]. Anaesthesia, Pain & Intensive Care, 2024, 28(2): 265-271.
-
Recurrent Hyperbilirubinemia - A Rare Case of Benign Recurrent Intrahepatic Cholestasis - A Diagnostic Challenge
Tolmane I. [J]. Insights of Clinical and Medical Images, 2024.
-
Clinical application of blood purification in polymyositis/ dermatomyositis
Jia J, Meng D, Zhang X, et al. [J]. Therapeutic Apheresis and Dialysis, 2024, 28(1): 112-118.
-
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup
Zarbock A, Nadim M K, Pickkers P, et al. [J]. Nature Reviews Nephrology, 2023, 19(6): 401-417.
-
Nomenclature of Extracorporeal Blood Purification Therapies for Acute Indications: The Nomenclature Standardization Conference
Ostermann M, Ankawi G, Cantaluppi V, et al. [J]. Blood Purification, 2024, 53(5): 358-372.
-
Extracorporeal Removal of Per- and Polyfluoroalkyl Substances by Hemoadsorption: In vitro Kinetic Model
Pavan P, Lorenzin A, Chiementin L, et al. [J]. Blood Purification, 2024: 1-11.
-
Hemadsorption to Contain Postoperative Cell-Free Hemoglobin and Haptoglobin Preservation for Extended Cardiopulmonary Bypass Time in Cardiac Surgery for Acute Kidney Injuries Prevention
Condello I, Morvillo J B, Fiore F, et al. [J]. Brazilian Journal of Cardiovascular Surgery, 2024, 39(3): e20230272.